Catherine Pearce, Chief Operating Officer at CinCor Pharma, Inc. (CINC), bought 2,250 shares at $16.00 ($36K) on 2022-01-11, disclosed to the SEC on 2022-01-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 750 | $12K | 33.3% |
| 2 | $16.00 | 1,500 | $24K | 66.7% |
| Total | $16.00 avg | 2,250 | $36K | 100% |